A group of U.S. senators is urging federal regulators to combat illegal online sales of abortion pills, highlighting connections to overseas suppliers, particularly in India.
WASHINGTON, DC – A coalition of U.S. senators has called on federal regulators to take action against the illegal online sale of abortion pills, specifically highlighting links to overseas supply chains, including those in India.
In a letter addressed to Food and Drug Administration (FDA) Commissioner Martin Makary on March 25, the lawmakers demanded “immediate action” to prevent “misbranded and unapproved versions of the chemical abortion drugs, mifepristone and misoprostol,” from entering the U.S. market.
The senators expressed concern that the illegal sale of these medications poses significant risks to women’s health and undermines the FDA’s core mission to protect American consumers.
They warned that the ease of online access to these drugs, without medical supervision, “poses serious risks to women’s health and increases the risk of forced and coerced abortions.”
The letter emphasizes the growing scale of the online market for abortion pills. One provider reportedly shipped 43,259 packages to 30 U.S. states within a year, while another estimate suggested that “as many as 100,000 packages” were imported into the U.S. in 2023 alone.
The senators identified four primary channels through which these drugs are being distributed: U.S.-based telehealth clinics, foreign clinics, informal networks, and online pharmacies. Many of these entities operate without prescriptions or adequate oversight.
Some websites have been found to falsely claim that they sell “FDA-approved” drugs, when in fact they are shipping unapproved versions sourced from overseas manufacturers.
The letter also raised alarm over safety concerns, noting that some platforms advise users not to disclose to their doctors that they have taken these drugs.
In response to these issues, the lawmakers urged the FDA to enhance its enforcement efforts. They called for the issuance of warning letters, actions against website domains, and improved coordination with customs and postal authorities to intercept illegal shipments.
Additionally, they requested that criminal investigations be initiated, referencing a 2020 case in which a U.S. resident was prosecuted for selling abortion pills sourced from India without prescriptions.
The senators emphasized that the FDA must “fully leverage its authorities” and prioritize addressing this pressing issue.
The letter was spearheaded by Senator Bill Cassidy and was co-signed by Senators Steve Daines, James Lankford, Cindy Hyde-Smith, and Lindsey Graham.
Medication abortion is widely utilized in the U.S., typically involving the administration of mifepristone followed by misoprostol under regulated conditions, according to IANS.